UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 11, 2007

SYMMETRY MEDICAL INC.

(Exact name of Registrant as specified in its charter)


Delaware

 

333-116038

 

35-1996126

(State or other jurisdiction

 

(Commission File Number)

 

(IRS Employer

of incorporation)

 

 

 

Identification No.)

 

220 West Market Street, Warsaw, Indiana 46580

(Address of Principal executive offices, including Zip Code)

(574) 268-2252

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 




TABLE OF CONTENTS

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

 

Item 9.01

Financial Statement and Exhibits

 

SIGNATURES

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

The Company announced Andrew J. Miclot’s resignation as Senior Vice President of Sales, Marketing, Business Development and Investor Relations, effective April 11, 2007. 

Fred L. Hite has been appointed to replace Mr. Miclot as the Company’s Investor Relations Officer, effective April 11, 2007.  Mr. Hite, age 38, will continue to serve in his current capacity as Senior Vice President and Chief Financial Officer of the Company, positions which he has held since 2004.  From 1997 to 2004, Mr. Hite served in various capacities at General Electric Industrial Systems, including Finance Manager of General Electric Motors and Controls from 2001 to 2004, Manufacturing Finance Manager from 2000 to 2001 and Finance Manager of Engineering Services from 1997 to 2000.

Item 9.01.

Financial Statements and Exhibits

 

(d)                                 Exhibits

99.1                           “Symmetry Medical Announces Departure of Andrew J. Miclot” Press Release issued by Symmetry Medical Inc. dated April 11, 2007.

2




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Symmetry Medical Inc.

 

 

 

 

 

/s/ Fred L. Hite

 

Date: April 13, 2007

Name:

Fred L. Hite

 

Title:

Chief Financial Officer

 

3